Xiangxue Pharmaceutical Co.,Ltd.
SZSE:300147.SZ
5.12 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 2,299.288 | 2,187.07 | 2,970.576 | 3,072.091 | 2,786.2 | 2,504.252 | 2,187.317 | 1,862.088 | 1,464.605 | 1,523.98 | 1,261.115 | 801.02 | 616.09 | 513.384 | 378.633 | 294.809 | 258.308 |
Kosten van de omzet
| 1,509.521 | 1,644.557 | 2,191.295 | 2,079.524 | 1,905.397 | 1,591.112 | 1,542.067 | 1,274.021 | 839.083 | 888.856 | 742.584 | 417.531 | 327.169 | 271.368 | 184.402 | 141.746 | 136.594 |
Brutowinst
| 789.766 | 542.513 | 779.281 | 992.566 | 880.803 | 913.14 | 645.25 | 588.067 | 625.522 | 635.124 | 518.531 | 383.489 | 288.921 | 242.016 | 194.232 | 153.063 | 121.713 |
Brutowinstmarge
| 0.343 | 0.248 | 0.262 | 0.323 | 0.316 | 0.365 | 0.295 | 0.316 | 0.427 | 0.417 | 0.411 | 0.479 | 0.469 | 0.471 | 0.513 | 0.519 | 0.471 |
Onderzoek- en ontwikkelingskosten
| 89.756 | 94.793 | 90.604 | 66.99 | 61.268 | 38.671 | 40.048 | 33.288 | 45.603 | 50.762 | 31.603 | 25.655 | 19.709 | 15.509 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 64.572 | 88.104 | 105.964 | 91.355 | 63.576 | 66.488 | 53.116 | 44.617 | 31.034 | 32.795 | 28.524 | 22.44 | 16.514 | 13.438 | 39.521 | 29.198 | 25.996 |
Verkoop- en marketingkosten
| 336.367 | 333.141 | 381.617 | 339.038 | 395.321 | 373.306 | 308.114 | 251.072 | 217.335 | 202.949 | 158.663 | 131.721 | 109.498 | 82.765 | 78.31 | 74.83 | 54.677 |
Verkoop-, algemene en administratieve kosten
| 400.939 | 421.245 | 487.581 | 430.393 | 458.897 | 439.794 | 361.23 | 295.689 | 248.369 | 235.744 | 187.187 | 154.161 | 126.012 | 96.203 | 117.831 | 104.028 | 80.673 |
Overige kosten
| -56.235 | 172.82 | 156.003 | 130.891 | 144.173 | -14.022 | 20.349 | 55.821 | 31.954 | 17.678 | 17.322 | 3.811 | 3.552 | 1.208 | 0.589 | 166.636 | -0.764 |
Bedrijfskosten
| 652.74 | 688.858 | 734.187 | 628.275 | 664.338 | 619.513 | 490.952 | 454.053 | 390.373 | 375.63 | 284.086 | 235.299 | 185.595 | 138.956 | 121.054 | 106.308 | 82.823 |
Bedrijfsresultaat
| -332.716 | -152.935 | 34.986 | 327.973 | 275.212 | 126.026 | 105.55 | 59.21 | 185.565 | 206.942 | 177.334 | 125.688 | 97.194 | 86.844 | 60.107 | 35.321 | 35.778 |
Bedrijfsresultaat ratio
| -0.145 | -0.07 | 0.012 | 0.107 | 0.099 | 0.05 | 0.048 | 0.032 | 0.127 | 0.136 | 0.141 | 0.157 | 0.158 | 0.169 | 0.159 | 0.12 | 0.139 |
Totaal overige inkomsten en kosten netto
| -56.235 | -361.781 | -670.761 | -161.834 | -158.135 | -14.022 | 20.349 | 55.389 | 31.937 | 17.653 | 17.322 | 3.811 | 3.552 | 1.208 | 0.589 | 5.356 | -0.764 |
Inkomen voor belasting
| -388.951 | -514.716 | -635.775 | 166.139 | 117.077 | 112.003 | 125.899 | 114.599 | 217.502 | 224.595 | 194.656 | 129.499 | 100.746 | 88.051 | 60.696 | 40.677 | 35.015 |
Inkomen voor belasting ratio
| -0.169 | -0.235 | -0.214 | 0.054 | 0.042 | 0.045 | 0.058 | 0.062 | 0.149 | 0.147 | 0.154 | 0.162 | 0.164 | 0.172 | 0.16 | 0.138 | 0.136 |
Belastingkosten
| 12.795 | -6.795 | 22.922 | 24.341 | -9.053 | 24.033 | 13.774 | 16.962 | 15.856 | 8.051 | 23.564 | 20.326 | 15.867 | 12.636 | 8.641 | 3.399 | 3.32 |
Nettowinst
| -388.964 | -507.921 | -658.697 | 141.797 | 126.13 | 56.439 | 65.939 | 66.024 | 177.298 | 196.796 | 158.243 | 107.168 | 83.497 | 74.199 | 50.917 | 35.951 | 30.781 |
Nettowinstmarge
| -0.169 | -0.232 | -0.222 | 0.046 | 0.045 | 0.023 | 0.03 | 0.035 | 0.121 | 0.129 | 0.125 | 0.134 | 0.136 | 0.145 | 0.134 | 0.122 | 0.119 |
WPA (Winst Per Aandeel)
| -0.59 | -0.77 | -1 | 0.22 | 0.19 | 0.09 | 0.1 | 0.1 | 0.28 | 0.32 | 0.33 | 0.18 | 0.14 | 0.16 | 0.13 | 0.09 | 0.078 |
Verwaterde WPA
| -0.59 | -0.77 | -1 | 0.22 | 0.19 | 0.09 | 0.1 | 0.1 | 0.28 | 0.32 | 0.33 | 0.18 | 0.14 | 0.16 | 0.13 | 0.09 | 0.078 |
EBITDA
| 263.037 | 89.362 | 184.899 | 463.295 | 389.99 | 438.475 | 424.505 | 298.605 | 374.648 | 372.083 | 311.87 | 203.271 | 144.866 | 123.821 | 87.807 | 227.55 | 53.701 |
EBITDA ratio
| 0.114 | 0.041 | 0.062 | 0.151 | 0.14 | 0.175 | 0.194 | 0.16 | 0.256 | 0.244 | 0.247 | 0.254 | 0.235 | 0.241 | 0.232 | 0.772 | 0.208 |